跳至主要内容
临床试验/ISRCTN85124072
ISRCTN85124072已完成未知

A randomised controlled trial of oral versus vaginal misoprostol for medical management of early foetal demise

South Tees Hospitals NHS Trust (UK)0 个研究点目标入组 240 人开始时间: 2009年4月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Women with an ultrasound diagnosis of (singleton) early foetal demise, with no medical contraindications or known allergy to misoprostol or mifepristone.

排除标准

  • 1. Heavy smokers (of >20 cigarettes day)
  • 2. Aged >35 years
  • 3. Severe asthma
  • 4. Cardiovascular disease, hypertension (blood pressure [BP] >160/100 mmHg)
  • 5. Chronic adrenal, renal or hepatic failure
  • 6. Porphyria or haemorrhagic disorders
  • 7. Long term corticosteroid
  • 8. Anticoagulant or non-steroidal anti-inflammatory drug (NSAID) therapy
  • 9. Known allergy to mifepristone or misoprostol

研究者

发起方
South Tees Hospitals NHS Trust (UK)

相似试验